Clinical Potential of VIP by Modified Pharmaco-kinetics and Delivery Mechanisms

E-ISSN： 2212-3873|12|4|344-350

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.12, Iss.4, 2012-12, pp. : 344-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Pravastatin: Mechanisms of Pharmacokinetic Events

By Hatanaka T.

Clinical Pharmacokinetics, Vol. 39, Iss. 6, 2000-12 ,pp. : 397-412

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Sterylglucoside-Modified Liposomes for Levonorgestrel Delivery via Nasal Route

By Ding Wu-Xiao Qi Xian-Rong Fu Qiang Piao Hui-Shan

Drug Delivery, Vol. 14, Iss. 2, 2007-02 ,pp. : 101-104

Informa Healthcare

Access to resources Recommend Favorite

Oral Mucosal Drug Delivery: Clinical Pharmacokinetics and Therapeutic Applications

By Zhang H.

Clinical Pharmacokinetics, Vol. 41, Iss. 9, 2002-01 ,pp. : 661-680

Adis International

Access to resources Recommend Favorite

The Potential of Flavonoids to Influence Drug Metabolism and Pharmacokinetics by Local Gastrointestinal Mechanisms

Current Drug Metabolism, Vol. 7, Iss. 7, 2006-10 ,pp. : 729-744

Bentham Science Publishers

Access to resources Recommend Favorite

The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential

Current Medicinal Chemistry, Vol. 17, Iss. 23, 2010-08 ,pp. : 2442-2455

Bentham Science Publishers

Access to resources Recommend Favorite